[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASN-183.
DOI=10.1126/science.2539641; PubMed=2539641 [NCBI, ExPASy, EBI, Israel, Japan]
Rao V.N.,
Huebner K.,
Isobe M.,
Ar-Rushdi A.,
Croce C.M.,
Reddy E.S.P.;
"elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints.";
Science 244:66-70(1989).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
DOI=10.1016/S0378-1119(98)00448-X; PubMed=9795224 [NCBI, ExPASy, EBI, Israel, Japan]
Harindranath N.,
Mills F.C.,
Mitchell M.P.,
Meindl A.,
Max E.E.;
"The human elk-1 gene family: the functional gene and two processed pseudogenes embedded in the IgH locus.";
Gene 221:215-224(1998).
|
[3]
|
NUCLEOTIDE SEQUENCE (ISOFORM 2).
Aryee D.N.T.,
Kovar H.;
"Novel family members HuER71, ELFR, and ELKv among ETS-related genes coexpressed with EWS-FLI1 in Ewing tumor cell lines.";
Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
TISSUE=Hippocampus;
DOI=10.1093/dnares/6.1.21; PubMed=10231026 [NCBI, ExPASy, EBI, Israel, Japan]
Yamauchi T.,
Toko M.,
Suga M.,
Hatakeyama T.,
Isobe M.;
"Structural organization of the human ELK1 gene and its processed pseudogene ELK2 genes.";
DNA Res. 6:21-27(1999).
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature03440; PubMed=15772651 [NCBI, ExPASy, EBI, Israel, Japan]
Ross M.T.,
Grafham D.V.,
Coffey A.J.,
Scherer S.,
McLay K.,
Muzny D.,
Platzer M.,
Howell G.R.,
Burrows C.,
Bird C.P.,
Frankish A.,
Lovell F.L.,
Howe K.L.,
Ashurst J.L.,
Fulton R.S.,
Sudbrak R.,
Wen G.,
Jones M.C.,
Hurles M.E., ![]()
Andrews T.D.,
Scott C.E.,
Searle S.,
Ramser J.,
Whittaker A.,
Deadman R.,
Carter N.P.,
Hunt S.E.,
Chen R.,
Cree A.,
Gunaratne P.,
Havlak P.,
Hodgson A.,
Metzker M.L.,
Richards S.,
Scott G.,
Steffen D.,
Sodergren E.,
Wheeler D.A.,
Worley K.C.,
Ainscough R.,
Ambrose K.D.,
Ansari-Lari M.A.,
Aradhya S.,
Ashwell R.I.,
Babbage A.K.,
Bagguley C.L.,
Ballabio A.,
Banerjee R.,
Barker G.E.,
Barlow K.F.,
Barrett I.P.,
Bates K.N.,
Beare D.M.,
Beasley H.,
Beasley O.,
Beck A.,
Bethel G.,
Blechschmidt K.,
Brady N.,
Bray-Allen S.,
Bridgeman A.M.,
Brown A.J.,
Brown M.J.,
Bonnin D.,
Bruford E.A.,
Buhay C.,
Burch P.,
Burford D.,
Burgess J.,
Burrill W.,
Burton J.,
Bye J.M.,
Carder C.,
Carrel L.,
Chako J.,
Chapman J.C.,
Chavez D.,
Chen E.,
Chen G.,
Chen Y.,
Chen Z.,
Chinault C.,
Ciccodicola A.,
Clark S.Y.,
Clarke G.,
Clee C.M.,
Clegg S.,
Clerc-Blankenburg K.,
Clifford K.,
Cobley V.,
Cole C.G.,
Conquer J.S.,
Corby N.,
Connor R.E.,
David R.,
Davies J.,
Davis C.,
Davis J.,
Delgado O.,
Deshazo D.,
Dhami P.,
Ding Y.,
Dinh H.,
Dodsworth S.,
Draper H.,
Dugan-Rocha S.,
Dunham A.,
Dunn M.,
Durbin K.J.,
Dutta I.,
Eades T.,
Ellwood M.,
Emery-Cohen A.,
Errington H.,
Evans K.L.,
Faulkner L.,
Francis F.,
Frankland J.,
Fraser A.E.,
Galgoczy P.,
Gilbert J.,
Gill R.,
Gloeckner G.,
Gregory S.G.,
Gribble S.,
Griffiths C.,
Grocock R.,
Gu Y.,
Gwilliam R.,
Hamilton C.,
Hart E.A.,
Hawes A.,
Heath P.D.,
Heitmann K.,
Hennig S.,
Hernandez J.,
Hinzmann B.,
Ho S.,
Hoffs M.,
Howden P.J.,
Huckle E.J.,
Hume J.,
Hunt P.J.,
Hunt A.R.,
Isherwood J.,
Jacob L.,
Johnson D.,
Jones S.,
de Jong P.J.,
Joseph S.S.,
Keenan S.,
Kelly S.,
Kershaw J.K.,
Khan Z.,
Kioschis P.,
Klages S.,
Knights A.J.,
Kosiura A.,
Kovar-Smith C.,
Laird G.K.,
Langford C.,
Lawlor S.,
Leversha M.,
Lewis L.,
Liu W.,
Lloyd C.,
Lloyd D.M.,
Loulseged H.,
Loveland J.E.,
Lovell J.D.,
Lozado R.,
Lu J.,
Lyne R.,
Ma J.,
Maheshwari M.,
Matthews L.H.,
McDowall J.,
McLaren S.,
McMurray A.,
Meidl P.,
Meitinger T.,
Milne S.,
Miner G.,
Mistry S.L.,
Morgan M.,
Morris S.,
Mueller I.,
Mullikin J.C.,
Nguyen N.,
Nordsiek G.,
Nyakatura G.,
O'dell C.N.,
Okwuonu G.,
Palmer S.,
Pandian R.,
Parker D.,
Parrish J.,
Pasternak S.,
Patel D.,
Pearce A.V.,
Pearson D.M.,
Pelan S.E.,
Perez L.,
Porter K.M.,
Ramsey Y.,
Reichwald K.,
Rhodes S.,
Ridler K.A.,
Schlessinger D.,
Schueler M.G.,
Sehra H.K.,
Shaw-Smith C.,
Shen H.,
Sheridan E.M.,
Shownkeen R.,
Skuce C.D.,
Smith M.L.,
Sotheran E.C.,
Steingruber H.E.,
Steward C.A.,
Storey R.,
Swann R.M.,
Swarbreck D.,
Tabor P.E.,
Taudien S.,
Taylor T.,
Teague B.,
Thomas K.,
Thorpe A.,
Timms K.,
Tracey A.,
Trevanion S.,
Tromans A.C.,
d'Urso M.,
Verduzco D.,
Villasana D.,
Waldron L.,
Wall M.,
Wang Q.,
Warren J.,
Warry G.L.,
Wei X.,
West A.,
Whitehead S.L.,
Whiteley M.N.,
Wilkinson J.E.,
Willey D.L.,
Williams G.,
Williams L.,
Williamson A.,
Williamson H.,
Wilming L.,
Woodmansey R.L.,
Wray P.W.,
Yen J.,
Zhang J.,
Zhou J.,
Zoghbi H.,
Zorilla S.,
Buck D.,
Reinhardt R.,
Poustka A.,
Rosenthal A.,
Lehrach H.,
Meindl A.,
Minx P.J.,
Hillier L.W.,
Willard H.F.,
Wilson R.K.,
Waterston R.H.,
Rice C.M.,
Vaudin M.,
Coulson A.,
Nelson D.L.,
Weinstock G.,
Sulston J.E.,
Durbin R.M.,
Hubbard T.,
Gibbs R.A.,
Beck S.,
Rogers J.,
Bentley D.R.;
"The DNA sequence of the human X chromosome.";
Nature 434:325-337(2005).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Uterus;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
PROTEIN SEQUENCE OF 318-331; 336-364 AND 380-408, PHOSPHORYLATION AT SER-324; THR-336; SER-383; SER-389 AND SER-422, AND MUTAGENESIS OF SER-324; THR-336; THR-353; THR-363; THR-368; SER-383; SER-389; THR-417 AND SER-422.
PubMed=7889942 [NCBI, ExPASy, EBI, Israel, Japan]
Gille H.,
Kortenjann M.,
Thomae O.,
Moomaw C.,
Slaughter C.,
Cobb M.H.,
Shaw P.E.;
"ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation.";
EMBO J. 14:951-962(1995).
|
[8]
|
DOMAINS.
DOI=10.1093/nar/20.13.3317; PubMed=1630903 [NCBI, ExPASy, EBI, Israel, Japan]
Janknecht R.,
Nordheim A.;
"Elk-1 protein domains required for direct and SRF-assisted DNA-binding.";
Nucleic Acids Res. 20:3317-3324(1992).
|
[9]
|
SUMOYLATION AT LYS-249, AND MUTAGENESIS OF LYS-230 AND LYS-249.
DOI=10.1016/S1097-2765(03)00265-X; PubMed=12887893 [NCBI, ExPASy, EBI, Israel, Japan]
Yang S.-H.,
Jaffray E.,
Hay R.T.,
Sharrocks A.D.;
"Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.";
Mol. Cell 12:63-74(2003).
|
[10]
|
SUMOYLATION AT LYS-230; LYS-249 AND LYS-254, AND MUTAGENESIS OF LYS-230; LYS-249 AND LYS-254.
DOI=10.1083/jcb.200310136; PubMed=15210726 [NCBI, ExPASy, EBI, Israel, Japan]
Salinas S.,
Briancon-Marjollet A.,
Bossis G.,
Lopez M.-A.,
Piechaczyk M.,
Jariel-Encontre I.,
Debant A.,
Hipskind R.A.;
"SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1.";
J. Cell Biol. 165:767-773(2004).
|
[11]
|
SUMOYLATION.
DOI=10.1016/S1097-2765(04)00060-7; PubMed=14992729 [NCBI, ExPASy, EBI, Israel, Japan]
Yang S.-H.,
Sharrocks A.D.;
"SUMO promotes HDAC-mediated transcriptional repression.";
Mol. Cell 13:611-617(2004).
|
[12]
|
INTERACTION WITH PIAS2.
DOI=10.1038/sj.emboj.7600690; PubMed=15920481 [NCBI, ExPASy, EBI, Israel, Japan]
Yang S.-H.,
Sharrocks A.D.;
"PIASx acts as an Elk-1 coactivator by facilitating derepression.";
EMBO J. 24:2161-2171(2005).
|
[13]
|
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-94.
DOI=10.1038/74055; PubMed=10742173 [NCBI, ExPASy, EBI, Israel, Japan]
Mo Y.,
Vaessen B.,
Johnston K.,
Marmorstein R.;
"Structure of the elk-1-DNA complex reveals how DNA-distal residues affect ETS domain recognition of DNA.";
Nat. Struct. Biol. 7:292-297(2000).
|
|
ExPASy Home page
SIB Switzerland
